T0	Outcomes 977 1031	interleukin-8 (IL-8) and tumor necrosis factor (TNF-α)
T1	Outcomes 1086 1197	the C-reactive protein (CRP), lactic acid dehydrogenase (LDH), white blood cell (WBC) count, amylase and lipase
T2	Outcomes 1393 1466	The plasma levels of IL-8, TNF-α, CRP, LDH, WBC count, amylase and lipase
T3	Outcomes 1602 1642	The plasma IL-8, TNF-α, CRP, lipase, LDH
T4	Outcomes 2070 2087	P<0.05 or P<0.01)
T5	Outcomes 2241 2253	there was no
T6	Outcomes 2341 2351	52 U/L vs.
T7	Outcomes 2352 2374	298 ± 71 U/L, P>0.05).
T8	Outcomes 2375 2378	The
T9	Outcomes 2581 2589	P<0.01).
T10	Outcomes 2590 2635	Compared with PN and EN groups, the incidence
T11	Outcomes 2639 2670	upper gastrointestinal bleeding
T12	Outcomes 2842 2872	13.4 ± 5.2 days, both P<0.01).
T13	Outcomes 2873 2897	There was no significant
T14	Outcomes 3034 3084	(bifidobacterium) resulted in significant lowering
T15	Outcomes 3092 3187	level of pro-inflammatory cytokines, earlier restoration of gastrointestinal function, decrease
T16	Outcomes 3191 3212	complications such as